Nanjing Hicin Pharmaceutical Co., Ltd.

SZSE:300584.SZ

24.7 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q4
Revenue 123.965129.024102.146136.976116.401144.347117.201147.252111.635116.974150.605124.793136.62154.699162.204158.342172.112209.669166.174239.942228.759245.237210.6186.284184.201177.823163.6153.276129.4196.76175.58786.61973.54869.20151.45967.774
Cost of Revenue 23.39427.42618.67835.99523.90724.42720.80536.60826.76926.57340.06727.11524.56126.6930.64437.2741.0858.52734.68560.43745.06542.91738.73625.65924.60222.77225.01728.3924.53222.37119.99525.923.3223.0618.92223.558
Gross Profit 100.571101.59983.468100.98292.494119.9296.396110.64484.86690.4110.53897.677112.059128.009131.559121.072131.032151.142131.489179.505183.693202.32171.864160.625159.599155.051138.583124.886104.87874.3955.59260.71950.22846.14232.53744.216
Gross Profit Ratio 0.8110.7870.8170.7370.7950.8310.8220.7510.760.7730.7340.7830.820.8270.8110.7650.7610.7210.7910.7480.8030.8250.8160.8620.8660.8720.8470.8150.810.7690.7350.7010.6830.6670.6320.652
Reseach & Development Expenses 14.5313.6435.4314.4488.52320.3643.0133.8123.356.2664.7893.0882.0418.8917.6778.1516.0739.0018.6511.8122.2210.18811.87813.9884.49834.6063.4940.657.43715.04023.62709.997018.227
General & Administrative Expenses 47.153-1.95318.42-32.04341.4570.10514.296-29.54538.059-9.44717.435-22.91132.822-4.98113.931-13.7578.58-2.0748.82-9.2017.668-1.5187.601-6.6838.54-4.919.403-29.84512.399-6.75311.476-21.78.954-4.1337.571-17.31
Selling & Marketing Expenses 58.83556.98638.59661.5756.75463.56459.70882.31557.53161.75467.10776.08581.24794.45191.09588.28100.063106.11190.977125.842140.105143.021122.227111.488117.599103.006105.86485.9370.27632.52729.99825.92428.03714.39217.50411.73
SG&A 105.98872.32156.8171.3898.21163.66874.00452.7795.58952.30784.54253.174114.06989.47105.02674.523108.643104.03799.797116.641147.773141.503129.827104.805126.13998.096115.26756.08582.67525.77341.4744.22436.9910.25925.075-5.579
Other Expenses -27.443-1.271-3.1191.507-0.2460.141-1.021-0.478-0.747-0.1950.094306.158-0.237-0.553-0.087-0.415-0.60.269-0.414-0.2360.0280.0760.027-0.241-0.4020.0520.043-1.055-0.156-0.3330.2520.1680.0320.486-0.0371.737
Operating Expenses 93.07587.23565.35884.32186.406108.83979.06899.35180.08180.99491.287100.288101.08118.356115.478109.086117.112126.465110.305152.282152.949164.505144.919134.138133.751127.958117.573103.47185.1649.54842.57543.06438.01727.66725.74225.015
Operating Income 3.0314.36418.1116.6612.9126.56214.6146.4442.0328.00113.624301.3637.297.92814.7196.94813.2922.39219.87723.77428.87936.00825.60524.10125.1426.63520.6424.45318.83725.5358.75716.50611.44717.9256.19818.163
Operating Income Ratio 0.0240.1110.1770.1220.0250.0450.1250.0440.0180.0680.092.4150.0530.0510.0910.0440.0770.1070.120.0990.1260.1470.1220.1290.1360.150.1260.160.1460.2640.1160.1910.1560.2590.120.268
Total Other Income Expenses Net -0.205-3.252-1.837-1.934-0.2460.141-1.021-0.478-0.747-0.1950.0940.024-0.237-0.553-0.087-0.415-0.60.269-0.414-0.2360.0280.0760.027-0.241-0.4020.0520.043-1.034-0.176-0.3340.252-0.0790.0140.486-0.0381.614
Income Before Tax 2.82511.11216.27314.7272.6676.70213.5945.9661.2857.80713.718301.3867.0537.37514.6336.53312.6922.6619.46323.53828.90736.08425.63323.8624.73926.68720.68323.41918.66125.2019.00916.42711.46218.4116.1619.778
Income Before Tax Ratio 0.0230.0860.1590.1080.0230.0460.1160.0410.0120.0670.0912.4150.0520.0480.090.0410.0740.1080.1170.0980.1260.1470.1220.1280.1340.150.1260.1530.1440.260.1190.190.1560.2660.120.292
Income Tax Expense -0.556-0.2672.9150.834-0.281-0.5591.38-6.4-1.0762.8581.2744.0840.221-0.0251.335-0.2091.0363.5652.4273.8344.2435.5633.3632.9343.1512.9653.6973.7152.1363.6881.1522.3861.4682.4550.9132.861
Net Income 3.3811.37913.35813.8932.9487.26112.21412.3662.3615.10112.621257.6457.0977.62613.516.8911.85419.31917.16719.79624.67130.52122.2720.92721.58723.72216.98719.70516.52521.5137.85714.049.99315.9565.24716.916
Net Income Ratio 0.0270.0880.1310.1010.0250.050.1040.0840.0210.0440.0842.0650.0520.0490.0830.0440.0690.0920.1030.0830.1080.1240.1060.1120.1170.1330.1040.1290.1280.2220.1040.1620.1360.2310.1020.25
EPS 0.0280.0950.110.120.0250.0610.10.10.020.0430.112.150.0590.0640.110.0580.0990.160.140.160.210.250.190.170.180.20.140.160.140.180.0710.150.110.180.0580.19
EPS Diluted 0.0280.0950.110.120.0250.0610.10.10.020.0430.112.150.0590.0640.110.0580.0990.160.140.160.210.250.190.170.180.20.140.160.140.180.0710.150.110.180.0580.19
EBITDA 5.05527.40321.25830.2086.85311.68216.50211.1214.2069.44619.578303.79610.8369.17916.14211.65113.34425.00220.85126.53730.97437.98327.68826.51725.9227.66721.50718.0312122.22117.31317.88712.50418.876.88821.69
EBITDA Ratio 0.0410.2120.2080.2210.0590.0810.1410.0760.0380.0810.132.4340.0790.0590.10.0740.0780.1190.1250.1110.1350.1550.1310.1420.1410.1560.1310.1180.1620.230.2290.2070.170.2730.1340.32